1
In-person
Aapro
Matti
President
SPCC and ALLCAN
2
In-person
Arnberg
Karl
Director Evidence & Access Policy
Novartis
3
In-person
Athanasiou
Dimitrios
Board of Directors
World Duchenne Organization - Rare Diseases Greece
4
In-person
Baldini
Benedetta
Senior Policy Advisor
ESIP (European Social Insurance Platform)
5
In-person
Barkei
Natalie
Director Public Affairs
DocMorris
6
In-person
Batchelor
Laura
Secretariat
RWE4Decisions Secretariat
7
In-person
Becker
Karin
Head, Health Economics & Outcomes Research, Centre of Excellence
Boehringer Ingelheim
8
In-person
Berg
Katja
Innovative Value and Access Strategy
AstraZeneca
9
In-person
Blonda
Alessandra
PhD Researcher
KU Leuven
10
In-person
Boselli
Simone
Public Affairs Director
EURORIDS-Rare Diseases Europe
11
In-person
Cardone
Antonella
CEO
Cancer Patients Europe
12
In-person
Carroll
Colm
Scientific Project Manager Digital Health
Innovative Health Initiative
13
In-person
Daems
Joël
HTA Expert CTG-CRM
RIZIV-INAMI
14
In-person
De Cock
Jo
Former CEO NIHDI
RIZIV-INAMI
15
In-person
De Cock
Rudy
Health & Value Director
Pfizer
16
In-person
Digneffe
Toon
Head Public Affairs & Partnerships Europe & Canada
Takeda
17
In-person
Eichler
Hans-Georg
Consulting Physician
Austrian Association of Social Insurances
18
In-person
Facey
Karen
Facilitator
RWE4Decisions
19
In-person
Facon
Pedro
Deputy administrator general
National Institute for Health and Disability Insurance (NIHDI)
20
In-person
Filonenko
Anna
Director RWE
Pfizer
21
In-person
Fronaschuetz
Ursula
Policy Officer - SANTE C.2
European Commission
22
In-person
Geale
Kirk
CEO
Quantify Research
23
In-person
Goovaerts
Hannah
Value & Evidence Lead BeLux
Pfizer
24
In-person
Hedberg
Niklas
Chief Pharmacist
TLV
25
In-person
Herteleer
Liesbet
Access Value Manager
Roche
26
In-person
Horsfield
Ali
Global Access Strategy Director
AstraZeneca
27
In-person
Jäger
Jens
Delegate for Health Research
Helmholtz Association of German Research Centres
28
In-person
Karan
Filip
RWE4Decisions
RWE4Decisions
29
In-person
Katrien
Delobelle
attaché
RIZIV-INAMI
30
In-person
Kent
Seamus
Assistant Professor
Erasmus University Rotterdam
31
In-person
Kenward
Rosalind
Account Director
FIPRA
32
In-person
Kleinermans
Diane
President of the Commission of Reimbursement of Medicines
RIZIV-INAMI
33
In-person
Lievevrouw
Elisa
Postdoctoral Researcher
KU Leuven
34
In-person
Limberopoulos
Thomas
Market Access & External Affairs Director BeLux
Roche
35
In-person
Marchã
Sofia
Director, Public Policy / Government Affairs & Lead Brussels Liaison
Biogen
36
In-person
Marsella
Marco
Director for Digital, EU4Health and Health systems modernisation, Directorate-General for Health and Food Safety
European Commission
37
In-person
Martichou
Vincent
Government Affairs Manager
Amgen
38
In-person
Maury
Eleonore
Medical Evidence Manager
Novartis
39
In-person
Meyer
François
Special Adviser
FIPRA
40
In-person
Natsis
Yannis
Director
European Social Insurance Platform (ESIP)
41
In-person
Natz
Alexander
Secretary General
EUCOPE
42
In-person
Olsen
Matias
Senior Manager, Public Affairs & Policy
EUCOPE
43
In-person
Pavel
Alina
Secretariat
RWE4Decisions
44
In-person
Rama
Serena
Secretariat
RWE4Decisions
45
In-person
Rannanheimo
Piia
Chief Specialist
Fimea
46
In-person
Roothans
Dessie
Dr
Solidaris
47
In-person
Rowark
Shaun
Associate Director - Data Access and Analysis
National Institute for Health and Care Excellence
48
In-person
Sauboin
Christophe
Global HEOR Capability Lead
Boehringer Ingelheim
49
In-person
Scholte
Marijn
Public Policy Analyst
European Society for Medical Oncology (ESMO)
50
In-person
Steenrod
Anna
Senior Director, Population Health Insights and Impact
Roche
51
In-person
Sutherland
Eric
Senior Health Economist
OECD
52
In-person
Terol Garcia
Enrique
Coordinating Advisor on Health
Permanent Representation of Spain to the European Union
53
In-person
Thomassin
Camille
Head of real-world evidence coordination unit - HTA Department
HAS
54
In-person
Van Nuwenborg
Jean
Senior consultant
Inovigate
55
In-person
Van de Casteele
Marc
Coordinator HTA pharmaceuticals
RIZIV-INAMI
56
In-person
Verpillat
Patrice
Head of RWE Workstream
European Medicines Agency
57
In-person
Vibhute
Neha
Manager Marketing and Corporate Communications
FIPRA International
58
In-person
Vidal Pinheiro
Andre
Head EUCAN Patient Value & Access
Takeda
59
In-person
Vroom
Elizabeth
CEO dutch Duchenne Parent Project, chair World Duchenne Organization
World Duchenne Organization
60
In-person
Westhovens
Rene
Prof Dr
KU Leuven
61
In-person
Xoxi
Entela
Senior Researcher
Università Cattolica del Sacro Cuore Roma
62
In-person
van Overbeeke
Eline
Director Access Strategy
Pfizer
1
Online
Almeida
Diogo
PhD Candidate
FFUL
2
Online
Arickx
Francis
Dir Pharma Policy
RIZIV-INAMI
3
Online
Asllanaj
Eralda
Senior Epidemiologist
Boehringer Ingelheim
4
Online
Babin
Celeste
Scientific projects manger
HAS
5
Online
Ballerand
Richard
Partner
Axolotl
6
Online
Barkats
Florence
RWE CCO
Cisiv
7
Online
Bianchi
Max
Junior Consultant
Harwood Levitt Consulting
8
Online
Bolt
Tresja
Senior healthcare advisor
Harwood Levitt Consulting
9
Online
Borga
Liyousew
Research Fellow
Luxembourg Institute of Health
10
Online
Breeveld
Vidya
Principal consultant
Keen Access Insights
11
Online
Bulejová
Lenka
Governmental affairs Manager
Takeda Pharmaceuticals
12
Online
Bulliard
Michelle
VP RWE
Iqvia
13
Online
Cammarata
Silvia
Manager
Aifa
14
Online
Chabane
Mounia
Global market access and HEOR manager
MC Consulting
15
Online
Chavade
Delphine
Market Access Director
Biodimed Conseils
16
Online
Cheng
Chiang-Min
medical
Roche
17
Online
Costa
Ines
HTA Assessor
INFARMED, I.P.
18
Online
Coteur
Jeff
Founder
iPATH Solutions
19
Online
De Barros
Jerome
Policy Officer
European Commission
20
Online
Dröge
Lennart
Junior Consultant
CONCILIUS Europe
21
Online
El Hayek
Ghinwa
Project Manager
Quinten Health
22
Online
Elgebaly
ISRAA
HTA consultant
UHIA
23
Online
Ersoy
Alara
Junior Associate
Dentons Global Advisors Europe SA
24
Online
Galea
Francesca
EMEA RWE Methods lead
Jansen
25
Online
Gebruers
Joppe
Consultant
Inovigate
26
Online
Gonzalez Vidal
Silvia
Blue Book Trainee - Policy Officer
European Commission - DG SANTE
27
Online
Groeneveld
Marianne
Senior Regulatory Manager
Pfizer
28
Online
Hamerlijnck
Dominique
Patient Expert
Atini
29
Online
Hanif
Shahid
Managing Director
GetReal Institute
30
Online
Harrison
Jillian
Researcher
KCE
31
Online
Hawkins
David
Managing Director
David
32
Online
Hawrot
Tadeusz
Founder and Executive Director
Psychedelic Access and Research European Alliance
33
Online
Heikkinen
Inka
Director, Global Regulatory Policy
MSD
34
Online
Hernlund
Emma
Analyst
TLV
35
Online
Higgins
Laura
Market Access Coordinator
WEP
36
Online
Holm-Larsen
Tove
CSO
Data Fair
37
Online
Hone
Devon
Director
McKesson
38
Online
Huang
Leah
Data scientist
Roche Taiwan
39
Online
Hulstaert
Frank
senior researcher
KCE
40
Online
Jaatinen
Julius
Consultatn
Acumen
41
Online
Janssens
François
Policy Officer
European Commission
42
Online
Jen
Min-Hua
Senior Director
Eli Lilly
43
Online
Jeong
Seung-Hee
RWE team lead
Pfizer
44
Online
Jonsson
Pall
Director Data and RWE
NICE
45
Online
Kahl
Joanna
Global Clinical Program Lead
Roche Diagnostics
46
Online
Kayaert
Hans
Partner
Falcon Bio
47
Online
Kinsella
Darren
Lead, Human Pharmaceuticals, Public & Government Affairs EU
Boehringer Ingelheim
48
Online
Kjaergaard
Maya
Medical science partner
Roche
49
Online
Klim
Lotte
HTA representative
Patient Organisation
50
Online
Klucken
Jochen
Full Professor
University of Luxembourg, Luxembourg Institute of Health
51
Online
Lajer
Maria
Med aff data Expert
Pfizer Denmark
52
Online
Lambert
Laurie
Senior Science Partner
CADTH
53
Online
Lin
Diana
Medical Advisor
Roche
54
Online
Macedo
Beatriz
Market Access Manager
Daiichi-Sankyo Portugal
55
Online
Maganete
Carolina
MAS Real World Data Expert
Pfizer
56
Online
Malik
Farzana
Managing Partner
Cogience
57
Online
Mendivil
Joan
Head Evidence and Outcomes Research
Pharvaris
58
Online
Mercurio
Vincenzo
Data Partnership Manager
BC Platforms
59
Online
Miotto
Federica
TPM
Fondazione Telethon
60
Online
Mulcock
Neil
Vice President, International Government Affairs
Gilead Science
61
Online
Murdock
Anna
Senior Account Executive
FleishmanHillard
62
Online
Negri
Daniela
Director
Weber Shandwick
63
Online
Nurkanovic
Larisa
Team Lead, RWE
Boehringer Ingelheim
64
Online
ODonnell
Peter
Press
APM
65
Online
Pemberton-Ross
Peter
Head, HE & HTA Strategy
Biogen
66
Online
Pilgaard
Trine
Director, Market Access
Pfizer
67
Online
Poulsen
Peter Bo
Sr Health Economics and Outcomes Research Manager
Pfizer Denmark
68
Online
Rafael Almeida
Sara
Policy Officer
European Commission, DG SANTE
69
Online
Rodwell
Charlotte
Partnerships, tech transfer and communications officer
Orphanet - INSERM US14
70
Online
Roobol
Stefan
Medical Affairs Scientist
Pfizer
71
Online
Schirghuber
Erika
Global Medical Science Leader
F. Hoffmann-La Roche Ltd.
72
Online
Shaikh
Javed
Director
Axtria Inc
73
Online
Shepelev
Julian
Market Access and HEOR, EMEA
Baxter Healthcare
74
Online
Siegersma
Klaske
Medical Affairs Data Expert
Pfizer
75
Online
Sonemann
Anja
Attaché International Collaboration
RIZIV-INAMI
76
Online
Sorrentino
Domenico
Analyst
Edelman Global Advisory
77
Online
Sotirelis
Chris
RWE4Decisions Steering Group member
CFT Florence
78
Online
Stromgren
Anna
Seconded National Expert
DG SANTE
79
Online
Tikkanen
Emmi
Senior medical affairs data expert
Pfizer
80
Online
Vallet
Mahéva
Senior research manager
University of Edinburgh
81
Online
Vanfraechem
Kristof
Ceo
Data for Patients
82
Online
Vivanco Hidalgo
Rosa
Head of HTA and Quality Unit
AQuAS
83
Online
Vo
Pamela
Global HEOR and Access Evidence
Novartis
84
Online
Wallace
Angus
Consultant
Harwood Levitt Consulting
85
Online
Wallington
Michael
Director (RWE)
Pfizer
86
Online
Wang
Junfeng
Assistant Professor
Utrecht University
87
Online
Warmuth
Marisa
HTA expert
Austrian Social Insurance
88
Online
Wiegers
Eveline
Postdoctoral researcher
Erasmus MC
89
Online
Williams
Bola
Senior Manager
Boston Scientific
90
Online
Wu
Lulu
RWD Scientist
Roche
91
Online
Zgodka
Dorota
Healthcare Principal
Experientia
92
Online
de Goeij
Michelle
Medical Affairs Scientist
Pfizer
93
Online
van Loon
Jeanni
Market Access Manager
Pfizer